Evidence map›Paper›PMID 10871852›Full record

ArticleOncogene2000

p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression.

V N Ivanov, Z Ronai

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The p38 MAPK stress pathway as a tumor suppressor or more?Frontiers in bioscience : a journal and virtual library · 2008
    Review
  13. Review
  14. Article
  15. Review
  16. Many faces of NF-kappaB signaling induced by genotoxic stress.Journal of molecular medicine (Berlin, Germany) · 2007
    Review
  17. Article
  18. NF-kappaB activation in melanoma.Pigment cell research · 2006
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

V N IvanovThe Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, NY 10029, USA.
Z Ronai
Icahn School of Medicine at Mount Sinai · US

Funding

FUNCTION OF ATF2--URE BINDING PROTEIN IN HUMAN MELANOMAR01CA051995 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 1996 to 2011
$4.0M
MECHANISMS OF UV-RADIATION INDUCIBLE PROTEIN EXPRESSIONR29CA051995 · NCI · INSTITUTE FOR CANCER PREVENTION · PI RONAI, ZE'EV A · 1991 to 1995
–
NCI NIH HHS CA51995
6 · The paper itself

Abstract

Identifying mechanisms that underlie the resistance of human melanoma to radiation and chemotherapy is expected to assist in developing new strategies for the treatment of this tumor type. We recently demonstrated that through up-regulation of TNFalpha, ATF2 increases the resistance of late stage melanoma cells to apoptosis induced by UV-irradiation. In elucidating the role of ATF2 kinases, we now demonstrate that ASK1/MKK6/p38 elicits suppression of Fas expression. ASK1/p38 downregulates the expression of a Fas via NF-kappaB/SP1 site on the Fas promoter. Deletion or mutation of NF-kappaB/SP1 within the Fas promoter abrogates p38 effect. ASK1/p38 silences the Fas promoter by inhibition of IkappaBalpha phosphorylation - thereby limiting NF-kappaB activity. Forced expression of a dominant negative form of p38 (p38-ASP) or treatment with p38 pharmacological inhibitor, SB203580, increases NF-kappaB activity, Fas expression and the levels of UVC-induced apoptosis in late stage melanoma cells. Inhibition of p38 activity also restored NF-kappaB activity and Fas expression in early-phase melanoma cells, suggesting that p38 elicited suppression of Fas expression is not restricted to late phase melanoma. Identifying p38-mediated down-regulation of Fas expression illustrates a novel regulatory pathway by which ASK1/MKK6/p38 alters the degree and nature of the UV-induced apoptosis of melanoma cells. Oncogene (2000).

Indexed as

Down-RegulationApoptosisfas ReceptorHumansMelanomaMitogen-Activated Protein KinasesNF-kappa Bp38 Mitogen-Activated Protein KinasesPromoter Regions, GeneticTumor Cells, CulturedUltraviolet Raysfas ReceptorMitogen-Activated Protein KinasesNF-kappa Bp38 Mitogen-Activated Protein Kinases

Identifiers

PMID10871852
OpenAlexW2003362851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.